FDA Inspection 1223241 — Rising Pharma Holding, Inc.
The FDA completed an inspection of Rising Pharma Holding, Inc. on November 3, 2023 in East Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 3, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- East Brunswick, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)